Comparison of diagnostic accuracy of In-111-pentetreotide SPECT and Ga-68-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours

S. Van Binnebeek, B. Vanbilloen, K. Baete, C. Terwinghe, M. Koole, F. M. Mottaghy, P. M. Clement, L. Mortelmans, K. Bogaerts, K. Haustermans, K. Nackaerts, E. Van Cutsem, C. Verslype, A. Verbruggen, C. M. Deroose

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)900-909
JournalEuropean Radiology
Volume26
Issue number3
DOIs
Publication statusPublished - Mar 2016

Keywords

  • Ga-68-DOTATOC
  • In-111-pentetreotide
  • SPECT
  • PRRT
  • Neuroendocrine tumour

Cite this

Van Binnebeek, S., Vanbilloen, B., Baete, K., Terwinghe, C., Koole, M., Mottaghy, F. M., Clement, P. M., Mortelmans, L., Bogaerts, K., Haustermans, K., Nackaerts, K., Van Cutsem, E., Verslype, C., Verbruggen, A., & Deroose, C. M. (2016). Comparison of diagnostic accuracy of In-111-pentetreotide SPECT and Ga-68-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours. European Radiology, 26(3), 900-909. https://doi.org/10.1007/s00330-015-3882-1